189 related articles for article (PubMed ID: 26888482)
1. Milder progressive cerebellar atrophy caused by biallelic SEPSECS mutations.
Iwama K; Sasaki M; Hirabayashi S; Ohba C; Iwabuchi E; Miyatake S; Nakashima M; Miyake N; Ito S; Saitsu H; Matsumoto N
J Hum Genet; 2016 Jun; 61(6):527-31. PubMed ID: 26888482
[TBL] [Abstract][Full Text] [Related]
2. Pontocerebellar hypoplasia type 2D and optic nerve atrophy further expand the spectrum associated with selenoprotein biosynthesis deficiency.
Pavlidou E; Salpietro V; Phadke R; Hargreaves IP; Batten L; McElreavy K; Pitt M; Mankad K; Wilson C; Cutrupi MC; Ruggieri M; McCormick D; Saggar A; Kinali M
Eur J Paediatr Neurol; 2016 May; 20(3):483-8. PubMed ID: 26805434
[TBL] [Abstract][Full Text] [Related]
3. Pontocerebellar hypoplasia type 2 and TSEN2: review of the literature and two novel mutations.
Bierhals T; Korenke GC; Uyanik G; Kutsche K
Eur J Med Genet; 2013 Jun; 56(6):325-30. PubMed ID: 23562994
[TBL] [Abstract][Full Text] [Related]
4. A SEPSECS mutation in a 23-year-old woman with microcephaly and progressive cerebellar ataxia.
van Dijk T; Vermeij JD; van Koningsbruggen S; Lakeman P; Baas F; Poll-The BT
J Inherit Metab Dis; 2018 Sep; 41(5):897-898. PubMed ID: 29464431
[TBL] [Abstract][Full Text] [Related]
5. A patient with pontocerebellar hypoplasia type 6: Novel RARS2 mutations, comparison to previously published patients and clinical distinction from PEHO syndrome.
Nevanlinna V; Konovalova S; Ceulemans B; Muona M; Laari A; Hilander T; Gorski K; Valanne L; Anttonen AK; Tyynismaa H; Courage C; Lehesjoki AE
Eur J Med Genet; 2020 Mar; 63(3):103766. PubMed ID: 31536827
[TBL] [Abstract][Full Text] [Related]
6. Biallelic CACNA1A mutations cause early onset epileptic encephalopathy with progressive cerebral, cerebellar, and optic nerve atrophy.
Reinson K; Õiglane-Shlik E; Talvik I; Vaher U; Õunapuu A; Ennok M; Teek R; Pajusalu S; Murumets Ü; Tomberg T; Puusepp S; Piirsoo A; Reimand T; Õunap K
Am J Med Genet A; 2016 Aug; 170(8):2173-6. PubMed ID: 27250579
[TBL] [Abstract][Full Text] [Related]
7. Selenoprotein biosynthesis defect causes progressive encephalopathy with elevated lactate.
Anttonen AK; Hilander T; Linnankivi T; Isohanni P; French RL; Liu Y; Simonović M; Söll D; Somer M; Muth-Pawlak D; Corthals GL; Laari A; Ylikallio E; Lähde M; Valanne L; Lönnqvist T; Pihko H; Paetau A; Lehesjoki AE; Suomalainen A; Tyynismaa H
Neurology; 2015 Jul; 85(4):306-15. PubMed ID: 26115735
[TBL] [Abstract][Full Text] [Related]
8. Biallelic
Ramadesikan S; Hickey S; De Los Reyes E; Patel AD; Franklin SJ; Brennan P; Crist E; Lee K; White P; McBride KL; Koboldt DC; Wilson RK
Cold Spring Harb Mol Case Stud; 2022 Feb; 8(2):. PubMed ID: 35091508
[TBL] [Abstract][Full Text] [Related]
9. Pontocerebellar hypoplasia type 1 for the neuropediatrician: Genotype-phenotype correlations and diagnostic guidelines based on new cases and overview of the literature.
Ivanov I; Atkinson D; Litvinenko I; Angelova L; Andonova S; Mumdjiev H; Pacheva I; Panova M; Yordanova R; Belovejdov V; Petrova A; Bosheva M; Shmilev T; Savov A; Jordanova A
Eur J Paediatr Neurol; 2018 Jul; 22(4):674-681. PubMed ID: 29656927
[TBL] [Abstract][Full Text] [Related]
10. Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy.
Agamy O; Ben Zeev B; Lev D; Marcus B; Fine D; Su D; Narkis G; Ofir R; Hoffmann C; Leshinsky-Silver E; Flusser H; Sivan S; Söll D; Lerman-Sagie T; Birk OS
Am J Hum Genet; 2010 Oct; 87(4):538-44. PubMed ID: 20920667
[TBL] [Abstract][Full Text] [Related]
11. Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients.
Cassandrini D; Cilio MR; Bianchi M; Doimo M; Balestri M; Tessa A; Rizza T; Sartori G; Meschini MC; Nesti C; Tozzi G; Petruzzella V; Piemonte F; Bisceglia L; Bruno C; Dionisi-Vici C; D'Amico A; Fattori F; Carrozzo R; Salviati L; Santorelli FM; Bertini E
J Inherit Metab Dis; 2013 Jan; 36(1):43-53. PubMed ID: 22569581
[TBL] [Abstract][Full Text] [Related]
12. BRF1 mutations alter RNA polymerase III-dependent transcription and cause neurodevelopmental anomalies.
Borck G; Hög F; Dentici ML; Tan PL; Sowada N; Medeira A; Gueneau L; Thiele H; Kousi M; Lepri F; Wenzeck L; Blumenthal I; Radicioni A; Schwarzenberg TL; Mandriani B; Fischetto R; Morris-Rosendahl DJ; Altmüller J; Reymond A; Nürnberg P; Merla G; Dallapiccola B; Katsanis N; Cramer P; Kubisch C
Genome Res; 2015 Feb; 25(2):155-66. PubMed ID: 25561519
[TBL] [Abstract][Full Text] [Related]
13. Novel mutations in TSEN54 in pontocerebellar hypoplasia type 2.
Battini R; D'Arrigo S; Cassandrini D; Guzzetta A; Fiorillo C; Pantaleoni C; Romano A; Alfei E; Cioni G; Santorelli FM
J Child Neurol; 2014 Apr; 29(4):520-5. PubMed ID: 23307886
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the Clinical Features and Imaging Findings of Pontocerebellar Hypoplasia Type 2D Caused by Mutations in SEPSECS Gene.
Zhao R; Zhang L; Lu H
Cerebellum; 2023 Oct; 22(5):938-946. PubMed ID: 36085396
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for early-onset neurological disorders caused by mutations in human selenocysteine synthase.
Puppala AK; French RL; Matthies D; Baxa U; Subramaniam S; Simonović M
Sci Rep; 2016 Aug; 6():32563. PubMed ID: 27576344
[TBL] [Abstract][Full Text] [Related]
16. Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations.
Rudnik-Schöneborn S; Senderek J; Jen JC; Houge G; Seeman P; Puchmajerová A; Graul-Neumann L; Seidel U; Korinthenberg R; Kirschner J; Seeger J; Ryan MM; Muntoni F; Steinlin M; Sztriha L; Colomer J; Hübner C; Brockmann K; Van Maldergem L; Schiff M; Holzinger A; Barth P; Reardon W; Yourshaw M; Nelson SF; Eggermann T; Zerres K
Neurology; 2013 Jan; 80(5):438-46. PubMed ID: 23284067
[TBL] [Abstract][Full Text] [Related]
17. Further delineation of pontocerebellar hypoplasia type 6 due to mutations in the gene encoding mitochondrial arginyl-tRNA synthetase, RARS2.
Glamuzina E; Brown R; Hogarth K; Saunders D; Russell-Eggitt I; Pitt M; de Sousa C; Rahman S; Brown G; Grunewald S
J Inherit Metab Dis; 2012 May; 35(3):459-67. PubMed ID: 22086604
[TBL] [Abstract][Full Text] [Related]
18. Extension of the phenotype of biallelic loss-of-function mutations in SLC25A46 to the severe form of pontocerebellar hypoplasia type I.
Braunisch MC; Gallwitz H; Abicht A; Diebold I; Holinski-Feder E; Van Maldergem L; Lammens M; Kovács-Nagy R; Alhaddad B; Strom TM; Meitinger T; Senderek J; Rudnik-Schöneborn S; Haack TB
Clin Genet; 2018 Feb; 93(2):255-265. PubMed ID: 28653766
[TBL] [Abstract][Full Text] [Related]
19. Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures.
Zhang X; Ling J; Barcia G; Jing L; Wu J; Barry BJ; Mochida GH; Hill RS; Weimer JM; Stein Q; Poduri A; Partlow JN; Ville D; Dulac O; Yu TW; Lam AT; Servattalab S; Rodriguez J; Boddaert N; Munnich A; Colleaux L; Zon LI; Söll D; Walsh CA; Nabbout R
Am J Hum Genet; 2014 Apr; 94(4):547-58. PubMed ID: 24656866
[TBL] [Abstract][Full Text] [Related]
20. [Early onset epileptic encephalopathy caused by mitochondrial arginyl-tRNA synthetase gene deficiency: report of two cases and literature review].
Jiang HF; Deng J; Fang F; Li H; Wang XH; Dai LF
Zhonghua Er Ke Za Zhi; 2020 Nov; 58(11):893-899. PubMed ID: 33120460
[No Abstract] [Full Text] [Related]
[Next] [New Search]
